Oculus Innovative Sciences Reports FY 2010 Financial Results and Reviews Upcoming Microcyn(R) Product Approvals and Introductions Jun 3, 2010
Oculus Innovative Sciences Launches Microcyn(R) Negative-Pressure Wound Therapy Solution for U.S. Market Jun 2, 2010
Oculus Innovative Sciences Announces Fiscal Fourth Quarter 2010 Financial Results and Corporate Update Release and Conference Call May 20, 2010
Oculus Innovative Sciences to Showcase New Microcyn(R) Wound and Skin Care Products Including Microcyn HydroGel at Symposium on Advanced Wound Care on April 17-20, 2010 in Orlando, Florida Apr 14, 2010
Oculus Innovative Sciences Launches Microcyn(R) Dermatology HydroGel for Relief of Pain and Itch into U.S. Dermatology Healthcare Market Mar 25, 2010
Oculus Innovative Sciences to Present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference Mar 11, 2010
Oculus Innovative Sciences Receives First FDA Clearance for Microcyn(R)-Based HydroGel for Dermatology Market with Claims Including Reduction of Itch and Pain Relief Mar 10, 2010
Oculus Innovative Sciences Reports Third Quarter FY 2010 Financial Results: 30% Reduction in Operating Expenses and 36% Increase in Product Revenue Feb 4, 2010
Oculus Innovative Sciences Introduces Microcyn(R) Solution for Use in Post-Surgical Wounds to U.S. Hospitals and Physicians Jan 28, 2010
